Skip to main content

CeGaT Standalone TMB Analysis

CeGaT is now offering the analysis of tumor mutational burden (TMB) as a standalone diagnostic. CeGaT's TMB analysis has been available since 2017, as a part of its Somatic Tumor Panel for Treatment Decisions. Offered as a stand-alone analysis, the TMB diagnostic is now available with shorter turnaround times, improved cost-efficiency, and features CeGaT's high quality.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.